The clinical march of bNAbs
27 January 2021
•
OA03
•
17:30
>
18:30
•
The clinical march of bNAbs
•
Live channel 1
17:30
•
OA03.01
•
Safety and single-dose pharmacokinetics of VRC07-523LS administered via different routes and doses
See abstract
17:38
•
OA03.02
•
Safety and PK of potent anti-HIV monoclonal ABÂ VRC07-523LS in HIV-exposed infants
See abstract
17:46
•
OA03.03LB
•
HIV-1 bnAb M4008_N1 targets a novel site of vulnerability at the V3 crown
See abstract
17:54
•
OA03.04LB
•
Analysis of genetic diversity and VRC01 pressure on HIV-1 breakthrough viruses from the AMP trial (HVTN 703/HPTN 081 and HVTN 704/085)
See abstract
18:02
•
OA03.05
•
Neutralization profiles of HIV-1 subtype C breakthrough viruses from the Southern African VRC01 AMP trial (HVTN 703/HPTN 081)
See abstract
18:10
•
OA03.06
•
Live Q&A
See abstract
|